Thanks celestial, the way I read the comment was there could be a problem with the dose being harmful due to the cells themselves.
If I am interpreting correctly what you are saying, is it finding the right dose to balance the reduction of the immune response enough to allow the build up of inmmflamation byproducts to reduce to levels that dont kill the patient?
- Forums
- ASX - By Stock
- MSB
- Cell Therapy News/Articles
MSB
mesoblast limited
Add to My Watchlist
2.33%
!
$1.65

Cell Therapy News/Articles, page-1167
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$1.65 |
Change
0.038(2.33%) |
Mkt cap ! $2.108B |
Open | High | Low | Value | Volume |
$1.60 | $1.66 | $1.60 | $2.104M | 1.284M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
20 | 32072 | $1.65 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.65 | 62328 | 13 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
24 | 44717 | 1.645 |
19 | 89436 | 1.640 |
18 | 71227 | 1.635 |
19 | 89023 | 1.630 |
14 | 115031 | 1.625 |
Price($) | Vol. | No. |
---|---|---|
1.650 | 50843 | 9 |
1.655 | 28108 | 14 |
1.660 | 96916 | 10 |
1.665 | 51582 | 8 |
1.670 | 209746 | 16 |
Last trade - 10.59am 26/06/2025 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |
The Watchlist
PTX
PRESCIENT THERAPEUTICS LIMITED
James McDonnell, CEO
James McDonnell
CEO
Previous Video
Next Video
SPONSORED BY The Market Online